시장보고서
상품코드
1193130

전기요법 시장 : 유형별, 용도별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

Electrotherapy Market By Type, By Application, By End User : Global Opportunity Analysis and Industry Forecast, 2021-2031

발행일: | 리서치사: Allied Market Research | 페이지 정보: 영문 280 Pages | 배송안내 : 2-3일 (영업일 기준)

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전기요법의 세계 시장은 2021년에 9억 7900만 달러, 2031년에는 16억 3640만 달러에 이르며 2022년부터 2031년에 걸쳐 CAGR 5.3%로 성장할 것으로 예측되고 있습니다.

전기요법은 전류를 사용하여 신체에 치료 효과를 제공하는 것입니다. 많은 물리 치료사들이 대상에 맞는 전기 자극으로 만성 통증, 근골격계 손상, 근육 쇠퇴, 신경통 등을 치료하는 강력한 도구가되었습니다. 전기요법은 피부 표면에서 신경과 근육을 자극하여 작동하는 부드럽고 비 침습적 인 양식입니다. 전기 자극은 신체의 통증 신호를 차단하거나 방해하여 통증을 완화시킵니다. 엔돌핀 (화학 전달 물질)을 방출하여 통증을 완화합니다. 근육 조직을 자극하고 수축시켜 위축을 억제함과 동시에 체내에서 가열 효과를 만들어 혈행을 좋게 치유를 촉진합니다.

전기요법 시장은 당뇨병 환자의 증가, 전기요법기 기술의 진보, 스포츠 부상의 증가에 의해 견인되고 있습니다. 당뇨병성 말초신경장애(DPN)는 당뇨병의 가장 흔한 합병증으로, 종종 고통스럽고 당뇨병 환자의 16%-33%가 이환되고 있습니다고 합니다. 당뇨병성 말초 신경 장애의 치료에는 다양한 종류의 전기요법이 사용됩니다. 또한 국제 당뇨병 연합에 따르면 2021년에는 전 세계에서 약 5억 3700만 명의 성인 인구가 당뇨병을 앓고 있다고 합니다. 당뇨병을 앓고 있는 사람의 총수는 2030년에는 6억 4,300만명, 2045년에는 7억 8,300만명으로 증가할 것으로 예측됩니다. 따라서 당뇨병의 유병률 증가는 전기요법의 수요를 촉진하고 시장 성장을 강화할 것으로 예상됩니다. 또한 전기요법에 관한 제품의 상시 및 승인의 증가가 시장 성장의 추진에 기여하고 있습니다. 예를 들어, 2022년 5월 의료기기 제조사인 Abbott Laboratories는 여러 통증 부위에 맞는 완화를 제공하는 새로운 척수 자극 시스템인 Proclaim Plus의 미국 식품의약국(FDA) 허가를 발표했습니다. .

고령자는 다른 연령대에 비해 정형외과 질환, 당뇨병, 전복에 의한 부상 등의 영향을 받기 쉽고, 그 결과 통증 유병률이 상승한다고 합니다. 따라서 노년 인구의 증가는 만성 통증 치료에 대한 전기요법의 수요를 높이고 전기요법 시장의 성장을 촉진하는 요인이되었습니다. 또한 세계 각국의 정부는 헬스케어 분야에 대한 지출을 늘리고 있습니다. 예를 들어, Medicare & Medicaid Service Center에 따르면 미국 의료비는 2019년부터 2020년까지 9.7% 증가하여 4조 1,000억 달러(1인당 12,530달러)에 이르렀습니다. 국가의 국내총생산에서 차지하는 의료비의 비율은 약 19.7%입니다. 마찬가지로 국가 통계국의 발표에 따르면 영국의 의료비 총액은 2019년 국내총생산(GDP)의 10.2%에 비해 2020년에는 12.8%를 차지하게 되었다. 게다가, 건강 관리 지출의 약 30%는 영국의 의료 인프라, 특히 공중 보건 센터(병원)에서 사용되는 의료 기기의 업그레이드에 사용되는 것으로 추정된다. 그러므로 이러한 세계 건강 관리 지출의 증가는 다양한 질병 치료에서 전기요법 응용에 대한 수요를 촉진하고 시장 성장을 뒷받침 할 것으로 예상됩니다.

한편, 전기요법과 만성통증의 치료에 관한 사람들의 인식 부족이 전기요법 시장의 성장을 억제할 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 개요

  • 시장의 정의와 범위
  • 주요 조사 결과
    • 주요 투자 포켓
  • Porter's Five Forces 분석
  • 주요 기업의 포지셔닝
  • 시장 역학
    • 촉진 요인
    • 억제 요인
    • 기회
  • COVID-19 영향 분석
  • 특허 상황

제4장 전기요법 시장 : 유형별

  • 개요
    • 시장 규모 및 예측
  • 경피적 전기신경 자극
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 치료용 초음파
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제5장 전기요법 시장 : 용도별

  • 개요
    • 시장 규모·예측
  • 통증 관리
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
    • 통증 관리 전기요법 시장 : 유형별
      • 요통의 시장 규모·예측 : 지역별
      • 목통의 시장 규모·예측 : 지역별
  • 불안·불면증 매니지먼트
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 스포츠 의학
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 기타
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제6장 전기요법 시장 : 최종 사용자별

  • 개요
    • 시장 규모·예측
  • 병원?진료소
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별
  • 재활 센터
    • 주요 시장 동향, 성장 요인, 기회
    • 시장 규모·예측 : 지역별
    • 시장 분석 : 국가별

제7장 전기요법 시장 : 지역별

  • 개요
    • 시장 규모·예측
  • 북미
    • 주요 동향과 기회
    • 북미 시장 규모·예측 : 유형별
    • 북미의 시장 규모·예측 : 용도별
      • 북미의 통증 관리용 전기요법기 시장 : 유형별
    • 북미 시장 규모·예측 : 최종 사용자별
    • 북미 시장 규모·예측 : 국가별
      • 미국
      • 캐나다
      • 멕시코
  • 유럽
    • 주요 동향과 기회
    • 유럽의 시장 규모·예측 : 유형별
    • 유럽의 시장 규모·예측 : 용도별
      • 유럽의 통증 관리용 전기요법기 시장 : 유형별
    • 유럽 시장 규모·예측 : 최종 사용자별
    • 유럽 시장 규모·예측 : 국가별
      • 독일
      • 프랑스
      • 영국
      • 이탈리아
      • 스페인
      • 기타 유럽
  • 아시아태평양
    • 주요 동향과 기회
    • 아시아태평양의 시장 규모·예측 : 유형별
    • 아시아태평양의 시장 규모·예측 : 용도별
      • 아시아태평양의 통증 관리용 전기요법기 시장 : 유형별
    • 아시아태평양의 시장 규모·예측 : 최종 사용자별
    • 아시아태평양의 시장 규모·예측 : 국가별
      • 중국
      • 일본
      • 인도
      • 호주
      • 기타 아시아태평양
  • LAMEA
    • 주요 동향과 기회
    • LAMEA의 시장 규모·예측 : 유형별
    • LAMEA의 시장 규모·예측 : 용도별
      • LAMEA의 통증 관리용 전기요법기 시장 : 유형별
    • LAMEA의 시장 규모·예측 : 엔드유저별
    • LAMEA의 시장 규모·예측 : 국가별
      • 브라질
      • 사우디아라비아
      • 남아프리카
      • 기타 LAMEA 지역

제8장 기업 정세

  • 소개
  • 주요 성공 전략
  • 주요 10개사의 제품 매핑
  • 경쟁 대시보드
  • 경합의 히트 맵
  • 주요 발전

제9장 기업 프로필

  • Abbott Laboratories
  • AliMed
  • Colfax
  • ems physio ltd
  • HMS Medical system
  • Medtronic, Inc.
  • Omron Healthcare
  • Palex Medical SA
  • Zynex Medical
  • Skin Inc.
ksm 23.03.27

The global electrotherapy market was valued at $979.0 million in 2021, and is projected to reach $1,636.4 million by 2031, registering a CAGR of 5.3% from 2022 to 2031. Electrotherapy is the use of electrical currents to produce therapeutic effects on the body. It is a powerful tool used by many physiotherapists to treat chronic pain, musculoskeletal injuries, muscle wasting, and nerve pain by using targeted & controlled electrical stimulation. Electrotherapy is a gentle & non-invasive modality that works by stimulating nerves & muscles through the surface of the skin. It sends out electrical impulses that block or interfere with the body's pain signals, leading to reduced pain. It helps to release endorphins (chemical messengers) that naturally decrease pain in the body. It stimulates muscle tissue to contract to reduce atrophy and creates a heating effect within the body which improves circulation & stimulates healing.

The electrotherapy market is driven by an increase in the prevalence of diabetes, advancement in technology in electrotherapy systems, and a rise in number of sports injuries. Diabetic peripheral neuropathy (DPN) is the most common complication of diabetes and is often associated with pain, affecting 16% to 33% of diabetes patients. Different types of electrotherapies are used to treat diabetic peripheral neuropathy. Further, according to the International Diabetes Federation, in 2021, approximately 537 million adult population across the globe suffered from diabetes. The total number of people suffering from diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Thus, rise in the prevalence of diabetes is anticipated to drive the demand for electrotherapy, thereby strengthening the market growth. In addition, rise in number of product launches & approvals for electrotherapy devices contributes to driving the market growth. For instance, in May 2022, Abbott Laboratories, a medical device manufacturing company, announced the approval of the U.S. Food and Drug Administration (FDA) for its new Proclaim Plus spinal cord stimulation system, which provides tailored relief to multiple pain areas.

The geriatric population is more susceptible to orthopedic disorders, diabetes, and fall injuries as compared to other age groups, which results in rise in the prevalence of pain. Thus, rise in geriatric population increases the demand for electrotherapy for the treatment of chronic pain which contributes to drive the growth of electrotherapy market. In addition, governments globally have increased the expenditure on the healthcare sector.  For instance, according to the Centers for Medicare & Medicaid Services, U.S. health care spending grew by 9.7% from 2019 to 2020 reaching $4.1 trillion ($12,530 per person).   As a share of the nation's Gross Domestic Product, healthcare spending accounted for around 19.7 %. Similarly, as per the Office for National Statistics, total healthcare expenditure in the UK accounted for 12.8% of the gross domestic product (GDP) in 2020, compared to 10.2% in 2019. Furthermore, it was estimated that approximately 30% of the healthcare expenditure is used in upgrading the healthcare infrastructure in the UK, especially medical equipment used at public health centers (hospitals). Hence, this rise in healthcare expenditure across the globe is expected to fuel the demand for electrotherapy applications in different disease treatments, thereby boosting market growth.

On the other hand, the lack of awareness among people regarding electrotherapy and the different options available for the treatment of chronic pain is anticipated to restrain the growth of the electrotherapy market.  

The global electrotherapy market is segmented on the basis of type, application, end-user, and region. On the basis of type, the market is segmented into transcutaneous electrical nerve stimulation, therapeutic ultrasound, and others. Other segments include electrical muscle stimulation, and interferential current (IC) therapy. By application, the market is classified into pain management, anxiety & insomnia management, sports medicine, and others. The pain management segment is divided into back pain and neck pain. Other segments include veterinary pain management, aesthetic, face lifting & toning. As per end user, the market is bifurcated into hospitals & clinics, and rehabilitation centers. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Some of the major companies that operate in the global electrotherapy market include Abbott, AliMed, Colfax, EMS Physio Ltd, HMS Medical system, Medtronic, OMRON Healthcare, Palex Medical, Skin Inc., and Zynex Medical.                        

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the electrotherapy market analysis from 2021 to 2031 to identify the prevailing electrotherapy market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the electrotherapy market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global electrotherapy market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

  • Transcutaneous electrical nerve stimulation
  • Therapeutic ultrasound
  • Others

By Application

  • Pain management
    • Type
    • Back pain
    • Neck pain
  • Anxiety and Insomnia Management
  • Sports Medicine
  • Others

By End User

  • Hospitals and clinics
  • Rehabilitation Centers

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest Of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest Of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest Of LAMEA
  • Key Market Players
    • Abbott Laboratories
    • AliMed
    • Colfax
    • ems physio ltd
    • HMS Medical system
    • Medtronic, Inc.
    • Omron Healthcare
    • Palex Medical SA
    • Zynex Medical
    • Skin Inc.

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key market segments
  • 1.3.Key benefits to the stakeholders
  • 1.4.Research Methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.Key findings of the study
  • 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
  • 3.3.Porter's five forces analysis
  • 3.4.Top player positioning
  • 3.5.Market dynamics
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.COVID-19 Impact Analysis on the market
  • 3.7.Patent Landscape

CHAPTER 4: ELECTROTHERAPY MARKET, BY TYPE

  • 4.1 Overview
    • 4.1.1 Market size and forecast
  • 4.2 Transcutaneous electrical nerve stimulation
    • 4.2.1 Key market trends, growth factors and opportunities
    • 4.2.2 Market size and forecast, by region
    • 4.2.3 Market analysis by country
  • 4.3 Therapeutic ultrasound
    • 4.3.1 Key market trends, growth factors and opportunities
    • 4.3.2 Market size and forecast, by region
    • 4.3.3 Market analysis by country
  • 4.4 Others
    • 4.4.1 Key market trends, growth factors and opportunities
    • 4.4.2 Market size and forecast, by region
    • 4.4.3 Market analysis by country

CHAPTER 5: ELECTROTHERAPY MARKET, BY APPLICATION

  • 5.1 Overview
    • 5.1.1 Market size and forecast
  • 5.2 Pain management
    • 5.2.1 Key market trends, growth factors and opportunities
    • 5.2.2 Market size and forecast, by region
    • 5.2.3 Market analysis by country
    • 5.2.4 Pain management Electrotherapy Market by Type
      • 5.2.4.1 Back pain Market size and forecast, by region
      • 5.2.4.2 Neck pain Market size and forecast, by region
  • 5.3 Anxiety and Insomnia Management
    • 5.3.1 Key market trends, growth factors and opportunities
    • 5.3.2 Market size and forecast, by region
    • 5.3.3 Market analysis by country
  • 5.4 Sports Medicine
    • 5.4.1 Key market trends, growth factors and opportunities
    • 5.4.2 Market size and forecast, by region
    • 5.4.3 Market analysis by country
  • 5.5 Others
    • 5.5.1 Key market trends, growth factors and opportunities
    • 5.5.2 Market size and forecast, by region
    • 5.5.3 Market analysis by country

CHAPTER 6: ELECTROTHERAPY MARKET, BY END USER

  • 6.1 Overview
    • 6.1.1 Market size and forecast
  • 6.2 Hospitals and clinics
    • 6.2.1 Key market trends, growth factors and opportunities
    • 6.2.2 Market size and forecast, by region
    • 6.2.3 Market analysis by country
  • 6.3 Rehabilitation Centers
    • 6.3.1 Key market trends, growth factors and opportunities
    • 6.3.2 Market size and forecast, by region
    • 6.3.3 Market analysis by country

CHAPTER 7: ELECTROTHERAPY MARKET, BY REGION

  • 7.1 Overview
    • 7.1.1 Market size and forecast
  • 7.2 North America
    • 7.2.1 Key trends and opportunities
    • 7.2.2 North America Market size and forecast, by Type
    • 7.2.3 North America Market size and forecast, by Application
      • 7.2.3.1 North America Pain management Electrotherapy Market by Type
    • 7.2.4 North America Market size and forecast, by End User
    • 7.2.5 North America Market size and forecast, by country
      • 7.2.5.1 U.S.
      • 7.2.5.1.1 Market size and forecast, by Type
      • 7.2.5.1.2 Market size and forecast, by Application
      • 7.2.5.1.3 Market size and forecast, by End User
      • 7.2.5.2 Canada
      • 7.2.5.2.1 Market size and forecast, by Type
      • 7.2.5.2.2 Market size and forecast, by Application
      • 7.2.5.2.3 Market size and forecast, by End User
      • 7.2.5.3 Mexico
      • 7.2.5.3.1 Market size and forecast, by Type
      • 7.2.5.3.2 Market size and forecast, by Application
      • 7.2.5.3.3 Market size and forecast, by End User
  • 7.3 Europe
    • 7.3.1 Key trends and opportunities
    • 7.3.2 Europe Market size and forecast, by Type
    • 7.3.3 Europe Market size and forecast, by Application
      • 7.3.3.1 Europe Pain management Electrotherapy Market by Type
    • 7.3.4 Europe Market size and forecast, by End User
    • 7.3.5 Europe Market size and forecast, by country
      • 7.3.5.1 Germany
      • 7.3.5.1.1 Market size and forecast, by Type
      • 7.3.5.1.2 Market size and forecast, by Application
      • 7.3.5.1.3 Market size and forecast, by End User
      • 7.3.5.2 France
      • 7.3.5.2.1 Market size and forecast, by Type
      • 7.3.5.2.2 Market size and forecast, by Application
      • 7.3.5.2.3 Market size and forecast, by End User
      • 7.3.5.3 UK
      • 7.3.5.3.1 Market size and forecast, by Type
      • 7.3.5.3.2 Market size and forecast, by Application
      • 7.3.5.3.3 Market size and forecast, by End User
      • 7.3.5.4 Italy
      • 7.3.5.4.1 Market size and forecast, by Type
      • 7.3.5.4.2 Market size and forecast, by Application
      • 7.3.5.4.3 Market size and forecast, by End User
      • 7.3.5.5 Spain
      • 7.3.5.5.1 Market size and forecast, by Type
      • 7.3.5.5.2 Market size and forecast, by Application
      • 7.3.5.5.3 Market size and forecast, by End User
      • 7.3.5.6 Rest of Europe
      • 7.3.5.6.1 Market size and forecast, by Type
      • 7.3.5.6.2 Market size and forecast, by Application
      • 7.3.5.6.3 Market size and forecast, by End User
  • 7.4 Asia-Pacific
    • 7.4.1 Key trends and opportunities
    • 7.4.2 Asia-Pacific Market size and forecast, by Type
    • 7.4.3 Asia-Pacific Market size and forecast, by Application
      • 7.4.3.1 Asia-Pacific Pain management Electrotherapy Market by Type
    • 7.4.4 Asia-Pacific Market size and forecast, by End User
    • 7.4.5 Asia-Pacific Market size and forecast, by country
      • 7.4.5.1 China
      • 7.4.5.1.1 Market size and forecast, by Type
      • 7.4.5.1.2 Market size and forecast, by Application
      • 7.4.5.1.3 Market size and forecast, by End User
      • 7.4.5.2 Japan
      • 7.4.5.2.1 Market size and forecast, by Type
      • 7.4.5.2.2 Market size and forecast, by Application
      • 7.4.5.2.3 Market size and forecast, by End User
      • 7.4.5.3 India
      • 7.4.5.3.1 Market size and forecast, by Type
      • 7.4.5.3.2 Market size and forecast, by Application
      • 7.4.5.3.3 Market size and forecast, by End User
      • 7.4.5.4 Australia
      • 7.4.5.4.1 Market size and forecast, by Type
      • 7.4.5.4.2 Market size and forecast, by Application
      • 7.4.5.4.3 Market size and forecast, by End User
      • 7.4.5.5 Rest of Asia-Pacific
      • 7.4.5.5.1 Market size and forecast, by Type
      • 7.4.5.5.2 Market size and forecast, by Application
      • 7.4.5.5.3 Market size and forecast, by End User
  • 7.5 LAMEA
    • 7.5.1 Key trends and opportunities
    • 7.5.2 LAMEA Market size and forecast, by Type
    • 7.5.3 LAMEA Market size and forecast, by Application
      • 7.5.3.1 LAMEA Pain management Electrotherapy Market by Type
    • 7.5.4 LAMEA Market size and forecast, by End User
    • 7.5.5 LAMEA Market size and forecast, by country
      • 7.5.5.1 Brazil
      • 7.5.5.1.1 Market size and forecast, by Type
      • 7.5.5.1.2 Market size and forecast, by Application
      • 7.5.5.1.3 Market size and forecast, by End User
      • 7.5.5.2 Saudi Arabia
      • 7.5.5.2.1 Market size and forecast, by Type
      • 7.5.5.2.2 Market size and forecast, by Application
      • 7.5.5.2.3 Market size and forecast, by End User
      • 7.5.5.3 South Africa
      • 7.5.5.3.1 Market size and forecast, by Type
      • 7.5.5.3.2 Market size and forecast, by Application
      • 7.5.5.3.3 Market size and forecast, by End User
      • 7.5.5.4 Rest of LAMEA
      • 7.5.5.4.1 Market size and forecast, by Type
      • 7.5.5.4.2 Market size and forecast, by Application
      • 7.5.5.4.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product Mapping of Top 10 Player
  • 8.4. Competitive Dashboard
  • 8.5. Competitive Heatmap
  • 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

  • 9.1 Abbott Laboratories
    • 9.1.1 Company overview
    • 9.1.2 Company snapshot
    • 9.1.3 Operating business segments
    • 9.1.4 Product portfolio
    • 9.1.5 Business performance
    • 9.1.6 Key strategic moves and developments
  • 9.2 AliMed
    • 9.2.1 Company overview
    • 9.2.2 Company snapshot
    • 9.2.3 Operating business segments
    • 9.2.4 Product portfolio
    • 9.2.5 Business performance
    • 9.2.6 Key strategic moves and developments
  • 9.3 Colfax
    • 9.3.1 Company overview
    • 9.3.2 Company snapshot
    • 9.3.3 Operating business segments
    • 9.3.4 Product portfolio
    • 9.3.5 Business performance
    • 9.3.6 Key strategic moves and developments
  • 9.4 ems physio ltd
    • 9.4.1 Company overview
    • 9.4.2 Company snapshot
    • 9.4.3 Operating business segments
    • 9.4.4 Product portfolio
    • 9.4.5 Business performance
    • 9.4.6 Key strategic moves and developments
  • 9.5 HMS Medical system
    • 9.5.1 Company overview
    • 9.5.2 Company snapshot
    • 9.5.3 Operating business segments
    • 9.5.4 Product portfolio
    • 9.5.5 Business performance
    • 9.5.6 Key strategic moves and developments
  • 9.6 Medtronic, Inc.
    • 9.6.1 Company overview
    • 9.6.2 Company snapshot
    • 9.6.3 Operating business segments
    • 9.6.4 Product portfolio
    • 9.6.5 Business performance
    • 9.6.6 Key strategic moves and developments
  • 9.7 Omron Healthcare
    • 9.7.1 Company overview
    • 9.7.2 Company snapshot
    • 9.7.3 Operating business segments
    • 9.7.4 Product portfolio
    • 9.7.5 Business performance
    • 9.7.6 Key strategic moves and developments
  • 9.8 Palex Medical SA
    • 9.8.1 Company overview
    • 9.8.2 Company snapshot
    • 9.8.3 Operating business segments
    • 9.8.4 Product portfolio
    • 9.8.5 Business performance
    • 9.8.6 Key strategic moves and developments
  • 9.9 Zynex Medical
    • 9.9.1 Company overview
    • 9.9.2 Company snapshot
    • 9.9.3 Operating business segments
    • 9.9.4 Product portfolio
    • 9.9.5 Business performance
    • 9.9.6 Key strategic moves and developments
  • 9.10 Skin Inc.
    • 9.10.1 Company overview
    • 9.10.2 Company snapshot
    • 9.10.3 Operating business segments
    • 9.10.4 Product portfolio
    • 9.10.5 Business performance
    • 9.10.6 Key strategic moves and developments
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제